On November 17, 2023, AMGEN Inc. (NASDAQ: AMGN) opened at $269.41, lower -1.34% from the last session. During the day, the shares moved up to $269.41 and dropped to $264.60 before settling in for the closing price of $269.00. Price fluctuations for AMGN have ranged from $211.71 to $291.60 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 2.81% over the past five years. Company’s average yearly earnings per share was noted 4.98% at the time writing. With a float of $534.01 million, this company’s outstanding shares have now reached $535.18 million.
Let’s look at the performance matrix of the company that is accounted for 25200 employees. In terms of profitability, gross margin is +75.45, operating margin of +35.78, and the pretax margin is +28.15.
AMGEN Inc. (AMGN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of AMGEN Inc. is 0.22%, while institutional ownership is 77.19%. The most recent insider transaction that took place on Nov 08, was worth 2,728,136. In this transaction EVP, Gen. Counsel & Secy. of this company sold 10,000 shares at a rate of $272.81, taking the stock ownership to the 28,078 shares. Before that another transaction happened on Sep 19, when Company’s 10% Owner bought 1,764,705 for $17.00, making the entire transaction worth $29,999,985. This insider now owns 35,368,653 shares in total.
AMGEN Inc. (AMGN) Latest Financial update
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted $4.96 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $4.67) by $0.29. This company achieved a net margin of +25.11 while generating a return on equity of 126.47. Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.21% during the next five years compared to 35.08% growth over the previous five years of trading.
AMGEN Inc. (NASDAQ: AMGN) Trading Performance Indicators
Check out the current performance indicators for AMGEN Inc. (AMGN). In the past quarter, the stock posted a quick ratio of 2.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.33. Likewise, its price to free cash flow for the trailing twelve months is 15.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 14.06, a number that is poised to hit 4.60 in the next quarter and is forecasted to reach 19.91 in one year’s time.
Technical Analysis of AMGEN Inc. (AMGN)
AMGEN Inc. (NASDAQ: AMGN) saw its 5-day average volume 2.29 million, a negative change from its year-to-date volume of 2.48 million. As of the previous 9 days, the stock’s Stochastic %D was 53.41%. Additionally, its Average True Range was 5.80.
During the past 100 days, AMGEN Inc.’s (AMGN) raw stochastic average was set at 67.05%, which indicates a significant increase from 62.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.10% in the past 14 days, which was higher than the 22.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $269.59, while its 200-day Moving Average is $245.27. Nevertheless, the first resistance level for the watch stands at $268.33 in the near term. At $271.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $273.14. If the price goes on to break the first support level at $263.52, it is likely to go to the next support level at $261.66. The third support level lies at $258.71 if the price breaches the second support level.
AMGEN Inc. (NASDAQ: AMGN) Key Stats
There are currently 535,178K shares outstanding in the company with a market cap of 142.03 billion. Presently, the company’s annual sales total 26,323 M according to its annual income of 6,552 M. Last quarter, the company’s sales amounted to 6,903 M and its income totaled 1,730 M.